3 days ago · Feb 18 (Reuters) - Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of ...

4 days ago · FRANKFURT, Feb 18 (Reuters) - Germany's Merck KGaA , opens new tab said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but it added ...

3 days ago · Get Merck & Co Inc (MRK.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

By Dan Levine and Mike Spector (Reuters) - Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties ...

NEW YORK/FRANKFURT (Reuters) -Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks...

3 days ago · Merck and a plaintiff suing the pharma have agreed to suspend a trial connected with the human papillomavirus vaccine Gardasil, according to an exclusive Tuesday report from Reuters.. The case is connected to newly confirmed Health and Human Services Secretary Robert F. Kennedy Jr., who in 2018 helped spearhead a mass legal action against Merck, as per a separate Reuters exclusive published ...

NEW YORK/FRANKFURT (Reuters) -Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics, according...

Feb 10, 2025 · Merck, in a statement, said its negotiations to buy SpringWorks are ongoing, confirming an earlier report from Reuters. The Darmstadt, Germany-based company said that no legally binding agreement ...

4 days ago · Merck (MRK) and a woman suing the company have agreed to pause a trial over alleged injuries linked to its human papillomavirus vaccine, a case connected to U.S. Department of Health and Human ...

Oct 31, 2024 · (Reuters) -Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's distributor there reduces inventories amid low demand, and the U.S....